Background: There are limited data on primary human immunodeficiency virus drug
resistance (HIVDR) in pediatric populations. This study aimed to assess the prevalence of …

We sought to determine the pattern of resistance-associated mutations (RAMs) among HIV-1-
infected children failing first-line antiretroviral therapy (ART) and ascertain their response to …

Objective: To investigate the prevalence and determinants of virologic failure and acquired
drug resistance-associated mutations (DRMs) in HIV-infected children and adolescents in …

Background: In the era of more efficacious prevention of mother-to-child transmission
(PMTCT) regimens, documenting the profile of drug resistance in HIV-infected infants and …

HIV-infected children are at high risk of acquiring drug-resistant viruses, which is of
particular concern in settings where antiretroviral drug options are limited. We aimed to …

Background A survey of drug resistance-associated mutations (DRMs) was conducted in
2009 among 77 vertically HIV-infected children not treated by antiretroviral drugs, followed …

Background Better understanding of drug resistance patterns in HIV-infected children on
antiretroviral therapy (ART) is required to inform public health policies in high prevalence …

Background: Children have an augmented risk of pretreatment HIV drug resistance (PDR)
due to exposure to antiretroviral drugs for the prevention of mother-to-child transmission …

Objectives To assess long-term virological efficacy and the emergence of drug resistance in
children who receive antiretroviral treatment (ART) in rural Tanzania. Patients and methods …

We report the presence of drug resistance mutations in 7.4%(2/27) of the treatment-naive,
HIV-1-infected children in Pune, India, who had HIV-1 RNA levels> 1,000 copies/ml …